Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Last revisionBoth sides next revision
home:mp:minocycline [10.13.2018] – [Safety] sallieqhome:mp:minocycline [09.02.2019] – [Minocycline] sallieq
Line 5: Line 5:
 Minocycline hydrochloride, also known as minocycline, is a broad spectrum tetracycline antibiotic, and was the base antibiotic of the Marshall Protocol. Minocycline hydrochloride, also known as minocycline, is a broad spectrum tetracycline antibiotic, and was the base antibiotic of the Marshall Protocol.
  
-Minocycline is recognized as a DMARD (Disease-Modifying Anti-Rheumatic Drug) by the American College of Rheumatology, which recommends its use as a treatment for mild rheumatoid arthritis.(({{pubmed>long:18512708}})) To minimize its [[home:othertreatments:antibacterials:highdose|dose-dependent immunosuppressive effects]], the Marshall Protocol uses minocycline at doses [[home:protocol:mp_antibiotics:dosing|much lower]] than otherwise prescribed by rheumatologists.+Minocycline is recognized as a DMARD (Disease-Modifying Anti-Rheumatic Drug) by the American College of Rheumatology, which recommends its use as a treatment for mild rheumatoid arthritis.(({{pubmed>long:18512708}})) To minimize its [[home:othertreatments:antibacterials:highdose|dose-dependent immunosuppressive effects]], the Marshall Protocol uses minocycline at pulsed doses [[home:protocol:mp_antibiotics:dosing|much lower]] than otherwise prescribed by rheumatologists.
  
 Either generic or brand name is appropriate to use. Either generic or brand name is appropriate to use.
Line 67: Line 67:
  
  
-{{tag>antibiotics MP}}+{{tag>Other_medication MP}}
  
 ===== Notes and comments ===== ===== Notes and comments =====
home/mp/minocycline.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.